GlaxoSmithKline Consumer Healthcare Q3 2012 Nov 2012

Press Release
Gurgaon, NCR India, Nov 1, 2012
 
GlaxoSmithKline Consumer Healthcare Ltd records high growth for Quarter 3 ended Sep 30, 2012

  • Domestic Sales up by 16% and Net Profits up by 25%

Overview________________________________________________________________________________

GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the third quarter ended Sept 30, 2012. Net Domestic sales recorded a healthy growth of 16% on account of higher net realisations and volume growth. This was despite the ongoing disturbance in the CSD business. Total reported Sales at Rs 828 crores recorded a growth of 15% over the same period in 2011 with PBT at Rs 190 crores growing by 24 % and PAT at Rs. 129 crores growing by 25%.

Commenting on the results, Mr. Zubair Ahmed, MD, GSKCH said, “The strong results in the third quarter are backed by innovation and strong leveraging of science that has helped us come up with a winning proposition on our flagship brand Horlicks. We are also striving to provide accessible nutrition to the masses through low unit price point packs backed by appropriate rural strategy that has seen us extend coverage to over 8000 villages and create awareness on nutrition and general wellbeing through village schools, aanganwadi centres and rural medicinal practitioners.”

The third quarter marked the relaunch of GSK CH India’s flagship brand - Horlicks, which challenged itself to become even better to meet and exceed changing consumer needs. Supplementing the previous “Taller, Stronger, Sharper” (TSS) proposition, Horlicks is now the only Health food drink clinically proven to provide comprehensive growth measured trough the ‘5 critical signs of growth’ as measured for a child’s development. Horlicks provides comprehensive growth for children by improving key aspects of growth i.e. more bone area, more muscles, better concentration, more active nutrients and healthier blood.

This quarter also saw GSK CH India’s entry into the digestive and diabetic biscuits space with Horlicks Nutribic. This launch marks the company’s foray into an entirely new category and adds to the company’s focus on enhancing the health and wellness portfolio. Horlicks Nutribic is designed to deliver specific health benefits to consumers who prefer products that are nutritive, convenient and hygienic.

About GlaxoSmithKline Consumer Healthcare Ltd.

GSKCH is an associate of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2900 people.

GSKCH has a strong marketing and distribution network in India comprising over 600 distributors and a direct coverage of over 7,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin, and Iodex as well as products from the global portfolio like BreatheRight and Sensodyne.

Media Contacts ______________________________________________________

Sakshi Mathur
Genesis Burson Marsteller
sakshi.mathur@bm.com+91 9999007585

Kuheli Ray
Genesis Burson Marsteller
kuheli.ray@bm.com+91 9999783541